Comment Comment by adamredwoods Petosemtamab (MCLA-158) is an investigational IgG1 antibody targeting EGFR.Merus's other trials (EGFR X c-MET) in NSCLC had serious side effects, but effective.https://www.fiercebiotech.com/biotech/merus-shares-dip-inter...Merus's pipeline, looks interesting:https://merus.nl/pipeline/ parent adamredwoods 2 years ago
Merus's other trials (EGFR X c-MET) in NSCLC had serious side effects, but effective.
https://www.fiercebiotech.com/biotech/merus-shares-dip-inter...
Merus's pipeline, looks interesting:
https://merus.nl/pipeline/